खोज परिणाम - Alessandra Ferrajoli

परिणाम को परिष्कृत करें
  1. 1
    An overview of prognostic markers in patients with CLL

    An overview of prognostic markers in patients with CLL द्वारा Julie Braish, Claudio Cerchione, Alessandra Ferrajoli

    प्रकाशित 2024
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Revisão
    सूची में सहेजें
    में बचाया:
  2. 2
    Invasive fungal infections in acute leukemia

    Invasive fungal infections in acute leukemia द्वारा Vijaya Raj Bhatt, George M. Viola, Alessandra Ferrajoli

    प्रकाशित 2011
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  3. 3
    Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review

    Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review द्वारा Francesco Autore, Paolo Strati, Luca Laurenti, Alessandra Ferrajoli

    प्रकाशित 2018
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Revisão
    सूची में सहेजें
    में बचाया:
  4. 4
    microRNA Therapeutics in Cancer — An Emerging Concept

    microRNA Therapeutics in Cancer — An Emerging Concept द्वारा Maitri Shah, Alessandra Ferrajoli, Anil K. Sood, Gabriel López-Berestein, George A. Călin

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Revisão
    सूची में सहेजें
    में बचाया:
  5. 5
    Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia

    Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia द्वारा Elihu H. Estey, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Stefan Faderl, Srđan Verstovšek, Dan Jones, Hagop M. Kantarjian

    प्रकाशित 2005
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  6. 6
    STAT-3 Activates NF-κB in Chronic Lymphocytic Leukemia Cells

    STAT-3 Activates NF-κB in Chronic Lymphocytic Leukemia Cells द्वारा Zhiming Liu, Inbal Hazan‐Halevy, David Harris, Ping Li, Alessandra Ferrajoli, Stefan Faderl, Michael J. Keating, Zeev Estrov

    प्रकाशित 2011
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  7. 7
    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia

    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia द्वारा Marco Montillo, Alessandra Tedeschi, Susan O’Brien, Francesco Di Raimondo, Susan Lerner, Alessandra Ferrajoli, Enrica Morra, Michael J. Keating

    प्रकाशित 2002
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  8. 8
    Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors

    Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors द्वारा Z Estrov, Razelle Kurzrock, Elihu H. Estey, Meir Wetzler, Alessandra Ferrajoli, David Harris, Mary Blake, JU Gutterman, Moshe Talpaz

    प्रकाशित 1992
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  9. 9
    First Report of Clinical Response to Venetoclax in Early T-Cell Precursor Acute Lymphoblastic Leukemia

    First Report of Clinical Response to Venetoclax in Early T-Cell Precursor Acute Lymphoblastic Leukemia द्वारा Yazan Numan, Mansour Alfayez, Abhishek Maiti, Yesid Alvarado, Elias Jabbour, Alessandra Ferrajoli, Sergej Konoplev, Hagop M. Kantarjian, Prithviraj Bose

    प्रकाशित 2018
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  10. 10
    Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine

    Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine द्वारा Gautam Borthakur, Samih El Ahdab, Farhad Ravandi, Stefan Faderl, Alessandra Ferrajoli, Beth Newman, Jean–Pierre J. Issa, Hagop M. Kantarjian

    प्रकाशित 2008
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  11. 11
    Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia

    Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia द्वारा Paolo Strati, William G. Wierda, Jan A. Burger, Alessandra Ferrajoli, Constantine S. Tam, Susan Lerner, Michael J. Keating, Susan O’Brien

    प्रकाशित 2013
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  12. 12
    Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia

    Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute ly... द्वारा Elias Jabbour, Susan O’Brien, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Farhad Ravandi, Maria E. Cabanillas, Deborah A. Thomas

    प्रकाशित 2007
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  13. 13
    STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells

    STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells द्वारा Inbal Hazan‐Halevy, David Harris, Zhiming Liu, Jie Liu, Ping Li, Xiaohong Chen, Sreejesh Shanker, Alessandra Ferrajoli, Michael J. Keating, Zeev Estrov

    प्रकाशित 2010
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  14. 14
    Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion

    Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion द्वारा Paolo Strati, Michael J. Keating, Susan O’Brien, Alessandra Ferrajoli, Jan A. Burger, S. Faderl, Francesco Paolo Tambaro, Nitin Jain, William G. Wierda

    प्रकाशित 2014
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  15. 15
    Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

    Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia द्वारा Lorenzo Falchi, Candida Vitale, Michael J. Keating, Susan Lerner, X. Wang, Kplola Y. Elhor Gbito, Sara S. Strom, William G. Wierda, Alessandra Ferrajoli

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  16. 16
    Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome

    Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome द्वारा Jorge E. Cortés, Patricia Ault, Charles Koller, Deborah Thomas, Alessandra Ferrajoli, William G. Wierda, Mary Beth Rios, Laurie Letvak, Elizabeth S. Kaled, Hagop M. Kantarjian

    प्रकाशित 2003
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  17. 17
    Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent <i>in‐situ</i> hybridization in 510 patients

    Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent <i>in‐situ</i> hybridization in 510 patien... द्वारा Constantine S. Tam, Joselle Otero‐Palacios, Lynne V. Abruzzo, Jeffrey L. Jorgensen, Alessandra Ferrajoli, William G. Wierda, Susan Lerner, Susan O’Brien, Michael J. Keating

    प्रकाशित 2008
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  18. 18
    Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

    Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia द्वारा Xavier C. Badoux, Michael J. Keating, Sijin Wen, William G. Wierda, Susan O’Brien, Stefan Faderl, Rachel L. Sargent, Jan A. Burger, Alessandra Ferrajoli

    प्रकाशित 2012
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  19. 19
    A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

    A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk m... द्वारा Stefan Faderl, Farhad Ravandi, Xuelin Huang, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Srđan Verstovšek, Deborah A. Thomas, Monica Kwari, Hagop M. Kantarjian

    प्रकाशित 2008
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  20. 20
    WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells

    WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells द्वारा Alessandra Ferrajoli, Stefan Faderl, Quin Van, Patricia E. Koch, David Harris, Zhiming Liu, Inbal Hazan‐Halevy, Yongtao Wang, Hagop M. Kantarjian, Waldemar Priebe, Zeev Estrov

    प्रकाशित 2007
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:

खोज साधन: